Patents by Inventor Adilson L. Guilherme

Adilson L. Guilherme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8519118
    Abstract: Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: August 27, 2013
    Assignee: University of Massachusetts
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Andrew D. Cherniack
  • Patent number: 8383600
    Abstract: Methods and compositions for modulating glucose transport are provided herein.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: February 26, 2013
    Assignee: University of Massachusetts
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Xiaoqing Tang
  • Publication number: 20120208862
    Abstract: Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
    Type: Application
    Filed: January 6, 2012
    Publication date: August 16, 2012
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Andrew D. Cherniack
  • Patent number: 8093223
    Abstract: Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: January 10, 2012
    Assignee: University of Massachusetts
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Andrew D. Cherniack
  • Patent number: 7790693
    Abstract: Methods and compositions for modulating glucose transport are provided herein.
    Type: Grant
    Filed: December 2, 2005
    Date of Patent: September 7, 2010
    Assignee: University of Massachusetts
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Xiaoqing Tang
  • Publication number: 20100098638
    Abstract: Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
    Type: Application
    Filed: October 8, 2009
    Publication date: April 22, 2010
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Andrew D. Cherniack
  • Patent number: 7691823
    Abstract: Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: April 6, 2010
    Assignee: University of Massachusetts
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Andrew D. Cherniack
  • Publication number: 20090221676
    Abstract: Methods and compositions for modulating glucose transport are provided herein.
    Type: Application
    Filed: February 26, 2009
    Publication date: September 3, 2009
    Applicant: University of Massachusettes
    Inventors: Michael P. Czech, Aimee Powelka, Adilson L. Guilherme, Xiaoqing Tang
  • Publication number: 20020155472
    Abstract: Nucleotide sequences and amino acid sequences from nucleic acids and proteins involved in glucose transport are disclosed. The sequences are useful for producing DNA arrays that can be used for the diagnosis of, predictive testing for, and development of treatments for disorders involving glucose transport such as type II diabetes.
    Type: Application
    Filed: October 22, 2001
    Publication date: October 24, 2002
    Inventors: Michael P. Czech, Andrew D. Cherniack, Adilson L. Guilherme